IP Library Granted Patent US 9,903,831
Granted Patent B2
US 9,903,831 · App. 14/354,387 · Granted Feb 27, 2018

Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte and derived biosensor parameters

Inventors: Michael Malecha (Muir of Ord, GB); Antony Smith (Inverness-shire, GB); David McColl (Inverness-shire, GB)
Assignee: LifeScan Scotland Limited
G01N27/3274G01N27/26G01N27/3272G06F19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,903,831
App. No.
14/354,387
Granted
Feb 27, 2018
Kind
B2
Abstract

Various embodiments for a method that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic, typically hematocrit, of the sample containing the analyte and deriving from this characteristic a parameter relating to the biosensor to attain accurate glucose concentration.

Claims (51)

1. A method of determining an analyte concentration from a fluid sample with a biosensor having at least two electrodes and a reagent disposed on at least one of the electrodes, the method comprising:

starting an analyte test sequence upon deposition of a sample on the biosensor;

applying a first signal to the sample to determine a physical characteristic of the sample wherein the physical characteristic is hematocrit level;

driving a second signal to the sample to cause a chemical transformation of the sample;

measuring at least one output signal from the sample;

obtaining a biosensor parametric factor from a look-up table or matrix based on the determined hematocrit level; and

calculating an analyte concentration based on the biosensor parametric factor and the at least one output signal measured at one of a plurality of predetermined time positions from the start of the test sequence based on the relationship:

G

1

=

[

I

E

-

P

1

P

2

*

x

2

]

where G 1 is the analyte concentration;

I E represents a total output signal of the electrodes of the biosensor measured at the one of the plurality of predetermined time positions;

P 1 represents a known batch intercept of the biosensor;

P 2 represents a known batch slope of the biosensor; and

x 1 represents the biosensor parametric factor based on the determined hematocrit level of the sample; and

annunciating the analyte concentration.

2. The method of claim 1 , in which the applying of the first signal and the driving of the second signal may be in sequential order.

3. The method of claim 1 , in which the applying of the first signal overlaps with the driving of the second signal.

4. The method of claim 1 , in which the applying of the first signal comprises directing an alternating signal to the sample so that the hematocrit level of the sample may be determined from an output of the alternating signal.

5. The method of claim 4 , in which the physical characteristic comprises an impedance characteristic representative of hematocrit level of the sample and the analyte comprises glucose.

6. The method of claim 5 , in which the applying of the first signal comprises including a step of driving first and second alternating signals at different respective frequencies in which a first frequency may be lower than the second frequency.

7. The method of claim 6 , in which the first frequency may be at least one order of magnitude lower than the second frequency.

8. The method of claim 7 , in which the first frequency comprises any frequency in the range of about 10 kHz to about 250 kHz.

9. The method of claim 1 , in which the one of the plurality of predetermined time positions for measuring at least one output signal during the test sequence may be about 2.5 seconds after a start of the test sequence.

10. The method of claim 9 , in which the one of the plurality of predetermined time positions comprises a time interval that overlaps a time point of 2.5 seconds after the start of the test sequence.

11. The method of claim 1 , in which another one of the plurality of predetermined time positions for measuring at least one output signal during the test sequence may be a time point of about 5 seconds after a start of the test sequence.

12. The method of claim 1 , in which one of the plurality of predetermined time positions comprises any time point at less than five seconds from a start of the test sequence.

13. The method of claim 12 , in which the another one of the plurality of predetermined time positions comprises any time point at less than ten seconds from a start of the test sequence.

14. The method of claim 13 , in which the one of the plurality of predetermined time positions comprises a time interval overlapping a time point of 2.5 seconds after the start of the test sequence and the another of the plurality of predetermined time positions comprises a time interval overlapping a time point of 5 seconds after the start of the test sequence.

15. The method of claim 1 , in which the at least two electrodes and at least two other electrodes are disposed in the same chamber provided on the substrate.

16. The method of claim 1 , in which the at least two electrodes comprise two electrodes to measure the hematocrit level and the analyte concentration.

17. The method of claim 1 , in which the at least two electrodes comprise a first set of at least two electrodes to determine the hematocrit level of the sample and a second set of at least two other electrodes to determine the analyte concentration.

18. The method of claim 17 , in which all of the electrodes are disposed on a same plane defined by a substrate of the biosensor.

19. The method of claim 16 , in which a third electrode may be disposed proximate the first set of at least two electrodes and connected to the second set of at least two other electrodes.

20. The system method of claim 18 , in which a reagent may be disposed proximate the second set of at least two other electrodes and no reagent may be disposed on the first set of at least two electrodes.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2016
From: MALECHA, MICHAEL; SMITH, ANTONY; MCCOLL, DAVID
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 037544/0361 →
Continuity (6)
Provisional Application 61581087 · Dec 29, 2011
Provisional Application 61581089 · Dec 29, 2011
Provisional Application 61581099 · Dec 29, 2011
Provisional Application 61581100 · Dec 29, 2011
Provisional Application 61654013 · May 31, 2012
Related Publication 20140284223A1 · Sep 25, 2014